BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2844402)

  • 1. Combined ultrastructural and biochemical study of cellular processing of vasoactive intestinal peptide and its receptors in human colonic carcinoma cells in culture.
    Hejblum G; Gali P; Boissard C; Astesano A; Marie JC; Anteunis A; Hui Bon Hoa D; Rosselin G
    Cancer Res; 1988 Nov; 48(21):6201-10. PubMed ID: 2844402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasoactive intestinal peptide receptor regulation and reversible desensitization in human colonic carcinoma cells in culture.
    Boissard C; Marie JC; Hejblum G; Gespach C; Rosselin G
    Cancer Res; 1986 Sep; 46(9):4406-13. PubMed ID: 3015387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restricted localization of functional vasoactive intestinal peptide (VIP) receptors in in vitro differentiated human colonic adenocarcinoma cells (HT29-D4).
    Fantini J; Martin JM; Luis J; Rémy L; Tirard A; Marvaldi J; Pichon J
    Eur J Cell Biol; 1988 Aug; 46(3):458-65. PubMed ID: 2846304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasoactive intestinal peptide receptor/adenylate cyclase system: differences between agonist- and protein kinase C-mediated desensitization and further evidence for receptor internalization.
    Turner JT; Bollinger DW; Toews ML
    J Pharmacol Exp Ther; 1988 Nov; 247(2):417-23. PubMed ID: 2846820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Desensitization to VIP by down regulation of its peptide receptors in transformed HT-29 cells of human colonic epithelium in culture].
    Boissard C; Hejblum G; Marie JC; Gespach C; Rosselin G
    C R Acad Sci III; 1984; 299(19):795-8. PubMed ID: 6099208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasoactive intestinal peptide (VIP) stimulates in vitro growth of VIP-1 receptor-bearing human pancreatic adenocarcinoma-derived cells.
    Jiang S; Kopras E; McMichael M; Bell RH; Ulrich CD
    Cancer Res; 1997 Apr; 57(8):1475-80. PubMed ID: 9108448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vasoactive intestinal peptide receptor in a human pancreatic carcinoma cell line].
    Chen Y
    Zhonghua Yi Xue Za Zhi; 1990 Mar; 70(3):135-7, 12. PubMed ID: 2163737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoactive intestinal peptide and intraocular pressure: adenylate cyclase activation and binding sites for vasoactive intestinal peptide in membranes of ocular ciliary processes.
    Mittag TW; Tormay A; Podos SM
    J Pharmacol Exp Ther; 1987 Apr; 241(1):230-5. PubMed ID: 3033201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross-competition between vasoactive intestinal peptide and somatostatin for binding to tumor cell membrane receptors.
    Virgolini I; Yang Q; Li S; Angelberger P; Neuhold N; Niederle B; Scheithauer W; Valent P
    Cancer Res; 1994 Feb; 54(3):690-700. PubMed ID: 7905785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chronic ethanol ingestion on the vasoactive intestinal peptide receptor-effector system from rat seminal vesicle membranes.
    Juarranz MG; Marinero MJ; Bodega G; Prieto JC; Guijarro LG
    Alcohol Clin Exp Res; 1999 Feb; 23(2):318-23. PubMed ID: 10069562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic AMP-dependent protein kinase in Molt 4b lymphoblasts: identification by photoaffinity labeling and activation in intact cells by vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI).
    O'Dorisio MS; Wood CL; Wenger GD; Vassalo LM
    J Immunol; 1985 Jun; 134(6):4078-86. PubMed ID: 2985703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HT 29, a model cell line: stimulation by the vasoactive intestinal peptide (VIP); VIP receptor structure and metabolism.
    Marchis-Mouren G; Martin JM; Luis J; el Battari A; Muller JM; Marvaldi J; Pichon J
    Biochimie; 1988 May; 70(5):663-71. PubMed ID: 2844304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoactive intestinal peptide control of cyclic adenosine 3':5'-monophosphate levels in seven human colorectal adenocarcinoma cell lines in culture.
    Laburthe M; Rousset M; Chevalier G; Boissard C; Dupont C; Zweibaum A; Rosselin G
    Cancer Res; 1980 Jul; 40(7):2529-33. PubMed ID: 6248206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium signal-mediated expression of the vasoactive intestinal polypeptide gene and its small contribution to activity-dependent survival of mouse cerebellar granule cells.
    Fukuchi M; Sakuragawa S; Tabuchi A; Tsuda M
    J Neurosci Res; 2004 Jul; 77(1):26-34. PubMed ID: 15197736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human H9 cells proliferation is differently controlled by vasoactive intestinal peptide or peptide histidine methionine: implication of a GTP-insensitive form of VPAC1 receptor.
    Goursaud S; Pineau N; Becq-Giraudon L; Gressens P; Muller JM; Janet T
    J Neuroimmunol; 2005 Jan; 158(1-2):94-105. PubMed ID: 15589042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology, molecular identification and functional characteristics of vasoactive intestinal peptide receptors in human breast cancer cells.
    Gespach C; Bawab W; de Cremoux P; Calvo F
    Cancer Res; 1988 Sep; 48(18):5079-83. PubMed ID: 2842044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular identification and structural requirement of vasoactive intestinal peptide (VIP) receptors in the human colon adenocarcinoma cell line, HT-29.
    Couvineau A; Rousset M; Laburthe M
    Biochem J; 1985 Oct; 231(1):139-43. PubMed ID: 2998337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suramin inhibits vasoactive intestinal peptide (VIP) binding and VIP-induced cAMP accumulation into two human cancerous cell lines.
    Bellan C; Pic P; Marvaldi J; Fantini J; Pichon J
    Second Messengers Phosphoproteins; 1991; 13(4):163-71. PubMed ID: 1667418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
    Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.